Dr. Brayman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4 Hospital Dr
Charlottesville, VA 22908Phone+1 434-924-9370Fax+1 434-924-5539
Education & Training
- Perelman School of Medicine at the University of PennsylvaniaClass of 1981
Certifications & Licensure
- VA State Medical License 2002 - 2026
- FL State Medical License 2019 - 2021
- PA State Medical License 1982 - 2002
- IL State Medical License 1991 - 1993
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
- Fellow (FACS) American College of Surgeons
Clinical Trials
- UVA Islet Cell Transplantation in Patients With Type I Diabetes Start of enrollment: 2007 Jan 01
Publications & Presentations
PubMed
- 342 citationsHuman β Cell Transcriptome Analysis Uncovers lncRNAs That Are Tissue-Specific, Dynamically Regulated, and Abnormally Expressed in Type 2 DiabetesIgnasi Moran, Ildem Akerman, Martijn van de Bunt, Ruiyu Xie, Marion Benazra
Cell Metabolism. 2012-10-03 - 133 citationsQuantifying temporal glucose variability in diabetes via continuous glucose monitoring: mathematical methods and clinical application.Boris P. Kovatchev, William L. Clarke, Marc D. Breton, Kenneth L. Brayman, Anthony L. McCall
Diabetes Technology & Therapeutics. 2005-12-30 - 12 citationsDelayed graft function and acute rejection following HLA-incompatible living donor kidney transplantationJennifer D. Motter, Kyle R. Jackson, Jane J. Long, Madeleine M. Waldram, Babak J. Orandi
American Journal of Transplantation. 2021-02-27
Journal Articles
- Healthy Donor Polyclonal IgM’s Diminish B Lymphocyte Autoreactivity, Enhance Treg Generation, and Reverse T1D in NOD MiceBlair T Stocks, Kenneth L Brayman, Daniel J Moore, Diabetes Care
Press Mentions
- Scientists Identify Potential Way to Prevent Type 1 DiabetesSeptember 26th, 2019
- PartnerSeptember 26th, 2019
- Lawsuits Drive Transplant Community Debate over Liver AllocationApril 24th, 2019
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: